Rasonque's $480,000 price tag exposes 20-year cancer drug inflation
Revolution Medicines' new pancreatic cancer treatment Rasonque carries a record annual cost, highlighting a decade-long trend of soaring oncology prices.

Loading the region desk
Gathering coverage from this region…
Executive intelligence curated from Americas sources and global coverage.
187 briefings briefings in Americas
Revolution Medicines' new pancreatic cancer treatment Rasonque carries a record annual cost, highlighting a decade-long trend of soaring oncology prices.
A Business Insider reporter attends the sold-out event and finds a crowd desperate for shortcuts, while Johnson himself admits the ultimate irony.
George Arison is pushing AI, healthcare, and long-distance matchmaking to turn Grindr into a super app - but investors are still skeptical.
From steel to maple syrup, the escalating trade dispute is raising costs for businesses and consumers on both sides of the 49th parallel.
As autonomous agents gain access to enterprise systems, security must shift from verifying identity to continuously validating behavior.
The K-pop group's 98,000-unit debut tops the chart while Dolly Parton's catalog reentry shows how death reshapes streaming.
A massive dump of Steam2 server data exposes cut Portal 2 content, prototypes, and decade-old secrets from 2003-2013.
President Trump doubled down on tariffs, telling U.S. businesses to stop importing Canadian goods and crediting his trade policy for reviving Ford and GM.
The massive leak includes beta builds and finished games, exposing unreleased code and raising piracy and security risks for developers.
A 12TB archive of Steam builds from 2003 to 2013 exposes Valve's lost Half-Life 2: Episode 3, the camera-driven F-Stop game, and years of untouched third-party prototypes.
Caterpillar's stock is no longer just a cyclical bet - it's riding the AI infrastructure boom, and investors are paying a premium for it.
The CEO's secretive in-house casting operation could reshape power markets, yet the fuel source is drawing legal and health scrutiny.